CYP-mediated therapeutic protein-drug interactions: clinical findings, proposed mechanisms and regulatory implications.
Therapeutic proteins (TPs) may affect the disposition of drugs that are metabolized by cytochrome P450 (CYP) enzymes, as is evident from a review of data in recently published literature and approved Biologic License Applications. Many TPs belonging to the cytokine class appear to differentially affect CYP activities. Cytokine modulators may affect CYP enzyme activities by altering cytokine effects on CYP enzymes. The alteration in CYP enzyme activities seems to result from changes in transcription factor activity for CYP enzyme expression or changes in CYP enzyme stability, which have been observed during altered immunological states such as infection and inflammation. Human growth hormone also appears to differentially affect CYP activities through unknown mechanisms. Because TP-drug interaction research is an evolving area, limited information is available during drug development on TP-drug interactions mediated by CYP inhibition or induction. The authors of this review suggest that effort be made to understand TP-drug interactions for the safe and effective use of TPs in combination with small-molecule drugs.
Lee
Jang-Ik
JI
Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, United States Food and Drug Administration, Silver Spring, Maryland 20993, USA. jangik.lee@fda.hhs.gov
Zhang
Lei
L
Men
Angela Y
AY
Kenna
Leslie A
LA
Huang
Shiew-Mei
SM
D000818:Animals; D003577:Cytochrome P-450 Enzyme System / Q000096:biosynthesis / Q000235:genetics / Q000493:pharmacokinetics / Q000502:physiology*; D004347:Drug Interactions / Q000502:physiology; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects; D006801:Humans; D007880:Legislation, Drug / Q000592:standards / Q000639:trends*; D008657:Metabolic Clearance Rate / Q000187:drug effects / Q000502:physiology; D004364:Pharmaceutical Preparations / Q000378:metabolism* / Q000592:standards; D011506:Proteins / Q000493:pharmacokinetics* / Q000592:standards / Q000627:therapeutic use*; D014481:United States
D004364:Pharmaceutical Preparations; D011506:Proteins; D003577:Cytochrome P-450 Enzyme System
J Clin Pharmacol. 2007 Sep;47(9):1104-18
17766698
Br J Clin Pharmacol. 1986 Nov;22(5):610-2
3790409
J Clin Endocrinol Metab. 1996 May;81(5):1999-2001
8626872
Clin Pharmacol Ther. 1978 Aug;24(2):213-8
679599
Mol Pharmacol. 1978 Jul;14(4):672-81
683177
Drug Metab Dispos. 2007 Sep;35(9):1687-93
17576808
Breast. 2004 Feb;13(1):28-34
14759713
Clin Pharmacol Ther. 2007 Feb;81(2):298-304
17259955
Clin Pharmacol Ther. 2009 Apr;85(4):434-8
19212314
Drug Metab Dispos. 2008 Feb;36(2):205-16
18218849
Lancet. 1978 May 27;1(8074):1132-3
77421
Hepatology. 1993 Jan;17(1):65-9
8423043
Annu Rev Pharmacol Toxicol. 2006;46:123-49
16402901
Br J Clin Pharmacol. 1989 Jun;27(6):795-802
2757895
Clin Transplant. 1997 Feb;11(1):38-41
9067693
Eur J Gastroenterol Hepatol. 1998 Jun;10(6):491-5
9855065
Lancet. 2000 Oct 14;356(9238):1327-8
11073027
Pediatr Pharmacol (New York). 1980;1(1):63-70
7346733
Annu Rev Immunol. 1993;11:165-90
8386517
Clin Pharmacol Ther. 2002 Mar;71(3):162-8
11907490
Clin Pharmacol Ther. 2000 Jan;67(1):32-43
10668851
Pediatrics. 1982 Apr;69(4):476-80
7070895
AAPS J. 2009 Jun;11(2):300-6
19418230
Clin Cancer Res. 2002 Aug;8(8):2480-7
12171873
Pharmacol Rev. 1990 Mar;42(1):1-28
2196590
Biochem Pharmacol. 1999 Apr 15;57(8):951-4
10086330
Pharmacol Ther. 2001 Nov-Dec;92(2-3):147-63
11916535
J Clin Pharmacol. 2008 Jun;48(6):662-70
18378963
Gastroenterology. 1995 Nov;109(5):1589-99
7557143
Dev Pharmacol Ther. 1989;12(2):90-5
2496962
Hepatology. 1993 Feb;17(2):230-5
7679086
Transplant Proc. 2002 Aug;34(5):1730-2
12176554
Drug Metab Rev. 1997 Nov;29(4):1129-88
9421688
Clin Pharmacol Ther. 1994 Jun;55(6):649-60
8004881
N Engl J Med. 1989 May 25;320(21):1420-1
2785642
Clin Pharmacol Ther. 2010 Apr;87(4):497-503
20200513
JAMA. 1983 Oct 21;250(15):1997-2001
6620499
Clin Ther. 2005 Dec;27(12):1942-8
16507380
Am J Ther. 2005 May-Jun;12(3):254-61
15891270
Drug Metab Dispos. 2000 Sep;28(9):1112-20
10950858
J Card Fail. 2002 Oct;8(5):315-9
12411982
Clin Pharmacol Ther. 2002 Jun;71(6):488-95
12087352
Br J Clin Pharmacol. 2000 Dec;50(6):605-13
11136300
Lancet. 1987 Oct 24;2(8565):939-41
2444839
Drug Metab Dispos. 2004 Jul;32(7):707-14
15205385
J Clin Pharmacol. 2007 Dec;47(12):1540-54
17962422
Transplantation. 1989 Apr;47(4):606-8
2523100